DK272287A - Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere - Google Patents

Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere

Info

Publication number
DK272287A
DK272287A DK272287A DK272287A DK272287A DK 272287 A DK272287 A DK 272287A DK 272287 A DK272287 A DK 272287A DK 272287 A DK272287 A DK 272287A DK 272287 A DK272287 A DK 272287A
Authority
DK
Denmark
Prior art keywords
inactivating
filterable
preparable
diseases
procedure
Prior art date
Application number
DK272287A
Other languages
English (en)
Other versions
DK272287D0 (da
Inventor
Johann Eibl
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK272287D0 publication Critical patent/DK272287D0/da
Publication of DK272287A publication Critical patent/DK272287A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DK272287A 1986-05-30 1987-05-27 Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere DK272287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0145786A AT390560B (de) 1986-05-30 1986-05-30 Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern

Publications (2)

Publication Number Publication Date
DK272287D0 DK272287D0 (da) 1987-05-27
DK272287A true DK272287A (da) 1987-12-01

Family

ID=3514329

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272287A DK272287A (da) 1986-05-30 1987-05-27 Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere

Country Status (8)

Country Link
US (1) US4814277A (da)
EP (1) EP0247998B1 (da)
JP (1) JP2506370B2 (da)
AT (2) AT390560B (da)
CA (1) CA1340062C (da)
DE (1) DE3786838D1 (da)
DK (1) DK272287A (da)
ES (1) ES2043689T3 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166763C (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
AT396937B (de) * 1992-04-06 1993-12-27 Immuno Ag Verfahren zur aktivierung von blutgerinnungsfaktoren
AU673589B2 (en) * 1993-03-15 1996-11-14 Pharma Pacific Pty Ltd Therapeutic formulation and method
JPH08509965A (ja) * 1993-03-15 1996-10-22 ファーマ・パシフィック・ピーティーワイ・リミテッド 治療剤および治療方法
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
DE19600939C1 (de) 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
WO1998009660A1 (en) * 1996-09-06 1998-03-12 Epic Therapeutics, Inc. Viral inactivation of biological fluids with biomolecule activity retention
AT405135B (de) * 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine
AT404358B (de) 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT410218B (de) 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
ES2477294T3 (es) 2007-08-13 2014-07-16 Baxter International Inc Modulación por IVIG de quimioquinas para el tratamiento de la esclerosis múltiple, la enfermedad de Alzheimer y la enfermedad de Parkinson
JP6335800B2 (ja) 2012-02-29 2018-05-30 バクスアルタ ゲーエムベーハー 末梢神経のIgG刺激性再ミエリン化法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2065196A (en) * 1934-10-09 1936-12-22 Parfentjev Ivan Alexandrovich Method for purification of antitoxins and the like
JPS5195125A (ja) * 1975-02-19 1976-08-20 Jomyakuchushayomenekiguroburinno seizoho
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
JPS567721A (en) * 1979-07-02 1981-01-27 Mochida Pharmaceut Co Ltd Preparation of immunoglobulin for intravenous injection
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
FR2507332A1 (fr) * 1981-06-04 1982-12-10 Roulot Maurice Source lumineuse polychromatique munie d'un deviateur de rayons lumineux et d'un correcteur d'aberration chromatique
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第7因子含有水溶液の加熱処理方法
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
JPS6049795A (ja) * 1983-08-31 1985-03-19 Kanai Hiroyuki 殺菌性繊維シ−ト

Also Published As

Publication number Publication date
DK272287D0 (da) 1987-05-27
ATA145786A (de) 1989-11-15
EP0247998A2 (de) 1987-12-02
ES2043689T3 (es) 1994-01-01
EP0247998B1 (de) 1993-08-04
DE3786838D1 (de) 1993-09-09
EP0247998A3 (en) 1989-12-27
JP2506370B2 (ja) 1996-06-12
CA1340062C (en) 1998-09-29
AT390560B (de) 1990-05-25
ATE92337T1 (de) 1993-08-15
JPS62286932A (ja) 1987-12-12
US4814277A (en) 1989-03-21

Similar Documents

Publication Publication Date Title
DK272287D0 (da) Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere
ATE42205T1 (de) Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten.
DK0519901T3 (da) Virusinaktiveret blodprodukt fremstillet ved behandling med varme og/eller detergent
MX7216E (es) Procedimiento mejorado para inactivar los virus presentes en composiciones que contienen enzimas del factor coagulante de la sangre
ATE44465T1 (de) Verfahren zur waermebehandlung einer den menschlichen blutgerinnungsfaktor viii enthaltenden waessrigen loesung.
HUT56133A (en) Process for treating viral infections with functional derivatives of icam-1 intercellular adhesion molecule
BR8706374A (pt) Processo de pasteurizacao de uma solucao aquosa de imunoglobulina
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DK161366C (da) Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere
ES511982A0 (es) "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".
ATE298582T1 (de) Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
ATE125713T1 (de) Verfahren zur inaktivierung der biologischen aktivität von dna.
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment